JATT II Acquisition Corp (JATT)
| Market Cap | 78.00M |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 7.80M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 87,947 |
| Open | 10.38 |
| Previous Close | 8.16 |
| Day's Range | 7.80 - 10.51 |
| 52-Week Range | 7.80 - 12.38 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About JATT
JATT II Acquisition is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to focus our search on healthcare and healthcare-related businesses, with a primary emphasis on biotechnology and broader life sciences.
News
JATT II's Biotech SPAC Debut: Sponsor's Varied History Faces a Doubtful Market
JATT II Acquisition: A New SPAC Targeting Biotech JATT II Acquisition, a newly formed blank check company focused on the biotech and life sciences sectors, | Bitget crypto news!
JATT II Acquisition IPO Registration Document (S-1)
JATT II Acquisition has filed to go public with an IPO on the NASDAQ
SPAC JATT II Acquisition files for a $60 million IPO, targeting biotech and life sciences
JATT II Acquisition, a blank check company targeting biotechs and life sciences businesses, filed on Friday with the SEC to raise up to $60 million in an initial public offering.